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Abstract
Treatment for 2 h with 200 WM cadmium chloride, followed by recovery, caused apoptosis and induced heat-shock protein
70 (HSP70) expression in U-937 promonocytic cells. However, pre-incubation with the GSH depleting agent L-buthionine-
[S,R]-sulfoximine (BSO, 1 mM for 24 h) caused necrosis instead of apoptosis and failed to induce HSP70 expression. This
failure was a consequence of necrosis instead of GSH depletion, since BSO allowed or even potentiated HSP70 induction
when used in combination with heat shock (2 h at 42.5‡C) or with 50 WM cadmium, which caused apoptosis. The
administration of N-acetyl-L-cysteine (NAC) at the beginning of recovery after BSO/200 WM cadmium treatment prevented
the execution of necrosis and restored the execution of apoptosis, but did not restore HSP70 induction, indicating that the
inhibition by BSO of HSP70 expression is an early regulated event. This contrasted with the capacity of NAC to prevent the
alterations caused by BSO/200 WM cadmium in other proteins, namely the suppression of Bax expression and the increase in
Bcl-2 and HSP-60 expression. Finally, it was observed that treatment with 200 WM cadmium rapidly increased the HSP70
mRNA level and stimulated heat-shock factor 1 (HSF1) trimerization and binding, and that these effects were prevented by
pre-incubation with BSO. Taken together, these results indicate that the stress response is compatible with apoptosis but not
with necrosis in cadmium-treated promonocytic cells. The suppression of the stress response is specifically due to the early
inhibition of HSF1 activation. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
One of the best-known properties of heavy metals
(and of other physical and chemical agents, collec-
tively known as inducers of the stress response) is the
capacity to stimulate the synthesis and accumulation
of heat-shock proteins (HSPs) [1]. The stress-pro-
voked induction of HSP genes is speci¢cally medi-
ated by the heat-shock factor 1 (HSF1). In un-
stressed cells, HSF1 is present in the cytoplasm as
a monomer or forming heteromeric complexes.
Upon stress, this transcription factor homotrimer-
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izes, translocates to the nucleus, and binds to its
DNA recognizing sequence (the heat-shock element,
or HSE) [2,3]. Finally, in a separately regulated re-
action, the DNA-bound HSF1 trimer is phosphory-
lated to fully acquire the transactivation capacity [4].
In addition, the stress inducers may provoke cell
death, either apoptotic or necrotic, depending on
the intensity of the treatments [5,6]. During apoptosis
the cells undergo nuclear and cytoplasmic shrinkage,
the chromatin is partitioned into multiple fragments,
and the cells are broken into multiple membrane-
surrounded bodies, but the cell membrane retains
its integrity. By contrast, necrosis is characterized
by cell swelling and rapid loss of the membrane in-
tegrity [7,8].
The relationship between stress response and cell
death is unclear, and seems to depend very much on
the cell type and the stress inducer used. For in-
stance, while a soft heat shock greatly induced
HSP70 and HSP27 expression in promyelocytic cells,
these proteins were slightly or not induced by drastic
thermal treatments which caused apoptosis or ne-
crosis [9]. However, other works reported that heat
shock and butyrate induced HSP70 expression in as-
sociation with apoptosis in lymphoid cells [10], and
tobacco smoke induced HSP70 expression in associ-
ation with both apoptosis and necrosis in promono-
cytic cells [6]. In addition, while most studies indi-
cated that the overexpression of HSPs (specially
HSP70 and HSP27) inhibited apoptosis induction
by di¡erent stimuli (for review see [11]), other works
indicated that HSP70 overexpression potentiated the
TCR- and Fas-induced apoptosis in lymphoid cells
[12], and that HSP27 overexpression potentiated the
toxicity of etoposide, tumor necrosis factor K and
H2O2 in mouse ¢brosarcoma L929 cells [13].
We had earlier reported that pulse-treatments with
150^200 WM cadmium chloride induced the stress
response [14] and caused death by apoptosis [15] in
U-937 human promonocytic cells. However, the cad-
mium treatment caused necrosis instead of apoptosis
if the cells were depleted of GSH by pre-incubation
with BSO [16,17]. In the present work we took ad-
vantage of this ¢nding to analyze the regulation of
the stress response during the cadmium-induced
apoptosis and necrosis.
2. Materials and methods
2.1. Cell culture and treatments
U-937 promonocytic leukemia cells [18] were rou-
tinely grown at densities of 1^6U105 cells/ml in
RPMI 1640 supplemented with 10% (v/v) heat-inac-
tivated fetal calf serum and 0.2% sodium bicarbonate
and antibiotics in a humidi¢ed 5% CO2 atmosphere
at 37‡C. Cadmium chloride (Merck, Darmstadt, Ger-
many) and DL-buthionine-[S,R]-sulfoximine (BSO,
Sigma Qu|¤mica, Madrid, Spain) were dissolved in
distilled water at 0.1 M before use. N-Acetyl-L-cys-
teine (NAC, Sigma) was dissolved in dimethyl sulf-
oxide at 3 M and stored at 320‡C. For heat shock,
the cultures were placed in a bath for 2 h at 42.5‡C
and then allowed to recover under standard culture
conditions. For cadmium treatment, the cells were
incubated for 2 h with the desired concentration of
cadmium chloride, then washed with pre-warmed
(37‡C) RPMI medium and allowed to recover under
standard culture conditions. As controls, cells were
subjected to the same manipulations as treated cells,
but without heating and cadmium addition. For
GSH depletion, the cells were incubated for 24 h
with 1 mM BSO, prior to heat or cadmium treat-
ment. The GSH depleting agent was maintained dur-
ing the treatment and recovery periods. Under these
conditions BSO reduced the intracellular GSH by
more than 90%, as determined with a Bioxytech
GSH-400 kit (OXIS International, Portland, OR),
but did not signi¢cantly a¡ect cell growth or viabil-
ity.
2.2. Determination of apoptosis and necrosis
Apoptosis was assessed by the presence of con-
densed and/or fragmented chromatin. With this
aim, cells were collected by centrifugation, washed
with phosphate bu¡ered saline (PBS), resuspended
in PBS and mounted on glass slides. After ¢xation
in 70% (v/v) ethanol, the cells were stained for 20
min at room temperature with 4,6-diamidino-2-phe-
nylindole (DAPI) (Serva, Heidelberg, Germany) at
the concentration of 1 Wg/ml in PBS, and examined
by £uorescence microscopy. The criterion used to
examine necrosis was the loss of membrane integrity,
as measured by trypan blue uptake.
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2.3. [3H]Valine incorporation
To estimate the relative rate of protein synthesis,
untreated cells or BSO-pre-treated cells were washed
twice with Hank’s solution and resuspended at the
concentration of 5U105 cells/ml in 4 ml of the same
solution containing 10 WCi of L-[3,4(n)-3H]valine (33
Ci/mmol) (Amersham Iberica, Madrid, Spain), either
in the absence or the presence of cadmium chloride
and BSO. At di¡erent times of incubation aliquots of
1 ml were collected by centrifugation and washed
twice with cold PBS, after which the radioactivity
incorporated into trichloroacetic acid precipitable
material was determined.
2.4. Measurement of protein content and immunoblot
assays
Samples of 5U106 cells were collected by centrifu-
gation, washed with PBS, and lysed according to
Laemmli’s procedure [19]. The protein content in
the resulting extracts was measured using the Bio-
Rad Protein Assay reagent (Bio-Rad Laboratories,
Madrid, Spain), following the procedure indicated
by the manufacturer. Detection of speci¢c protein
levels was carried out by immunoblot using SDS^
PAGE, as previously described [20]. The concentra-
tions of polyacrylamide used were 6.5% for analysis
of HSF1, and 10% for HSP70, HSP60, Bcl-2, Bax
and L-tubulin. The antibodies used were: mouse
anti-human HSP70 mAb (clone C92F34-5), mouse
anti-human HSP60 mAb (clone LK-1), and rabbit
anti-human HSF1 pAb (StressGen Biotechnologies,
Victoria, Canada); mouse anti-human Bcl-2 mAb
and rabbit anti-human Bax pAb (Santa Cruz Bio-
technology, Santa Cruz, CA); and mouse anti-chick-
en L-tubulin mAb (Amersham International, Little
Chalfont, UK).
For determinations of HSF1 oligomerization, the
cells were lysed and the proteins analyzed by immu-
noblot using native gradient (5^20%) PAGE, follow-
ing the conditions described by Baler et al. [2].
2.5. RNA blot assays
Total cytoplasmic RNA was extracted using an
Ultraspect -II RNA isolation kit (Biotecx Laborato-
ries, Houston, TX), following the procedure de-
scribed by the manufacturer. All other conditions
as well as the source of the HSP70, c-jun and c-fos
cDNA probes were as previously described [14,20].
2.6. Gel retardation assays
The whole procedure, including preparation of nu-
clear extracts, oligoprobe synthesis and labeling, con-
ditions of binding reaction, determination of binding
speci¢city, and electrophoretic separation, were as
previously described [16].
3. Results
3.1. Death induction and HSP70 expression
First, we examined the capacity of 2 h pulse-treat-
ments with increasing concentrations of cadmium
chloride (from 50 to 1000 WM), followed by recovery,
to cause apoptosis and necrosis in U-937 cells. While
the concentration of 50 WM was innocuous, higher
concentrations induced death by apoptosis, as deter-
mined by chromatin condensation and fragmenta-
tion, reaching approximately 50% apoptotic cells at
6 h of recovery after treatment with 200 WM cadmi-
um (Fig. 1A). Higher concentrations did not signi¢-
cantly increase apoptosis, probably due to the satu-
ration of the cadmium uptake system [14]. Under
these conditions the treatments caused little necrosis,
as determined by trypan blue exclusion (Fig. 1A).
Pre-incubation for 24 h with the GSH depleting
agent BSO (1 mM) potentiated the cadmium toxicity.
Thus, BSO increased the frequency of apoptosis and
also caused necrosis to some extent when used with
50 and 100 WM cadmium, and switched the mode of
death from apoptosis to necrosis when used with 200
WM cadmium (Fig. 1B). The expression of other ap-
optotic and necrotic markers, and the time-course
execution of apoptosis and necrosis upon treatment
with 200 WM cadmium, either with or without BSO,
were examined in earlier works [15,16] and hence are
omitted here. By contrast heat-shock treatment (2 h
at 42.5‡C), included as a control, only caused death
by apoptosis, either with or without pre-incubation
with BSO (Fig. 1A,B).
Then, we wanted to analyze the capacity of cad-
mium to induce the stress response under the di¡er-
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ent assayed conditions, as measured by the stimula-
tion of HSP70 expression. The results are indicated
in Fig. 2. Treatment with 200 WM cadmium caused a
progressive increase in HSP70 protein levels, starting
at 1 h of recovery, which was abolished by pre-in-
cubation with BSO (Fig. 2A). By contrast, pre-incu-
bation with BSO followed by heat shock, which as
indicated above only caused apoptosis, allowed
HSP70 induction (Fig. 2B); and pre-incubation
with BSO followed by treatment with 50 WM cadmi-
um, which caused some amount of necrosis but pref-
erentially potentiated apoptosis, also potentiated
HSP70 induction when compared with cells treated
with 50 WM cadmium alone (Fig. 2C). Hence, the
abrogation of HSP70 expression by BSO plus 200
WM cadmium seems to be associated to necrosis in-
duction, and may not be explained by GSH depletion
itself.
Fig. 1. Induction of cell death by cadmium and heat shock,
and its modulation by BSO. (A) U-937 cells were either left un-
treated (Cont), treated for 2 h with the indicated concentrations
of cadmium chloride (Cd), or heated for 2 h at 42.5‡C (HS),
and then allowed to recover for 6 h under standard culture
conditions. (B) Cells were incubated for 24 h with 1 mM BSO,
and then either left untreated (BSO) or subjected treatments
with cadmium (BSO/Cd) and heat (BSO/HS) and recovery as
above, always in the presence of BSO. The frequency of apo-
ptotic and necrotic cells was determined by chromatin fragmen-
tation and trypan blue uptake, respectively. The values are rep-
resentative of one of three determinations with similar results.
Fig. 2. Induction HSP70 protein expression by cadmium and
heat shock, and its modulation by BSO. (A) Relative HSP70
protein levels in untreated cells (Cont) and in cells treated with
200 WM cadmium chloride and allowed to recover for the indi-
cated time periods, either with (+) or without (3) pre-incuba-
tion with BSO, as determined by SDS^PAGE. (B) Similar ex-
periment using heat shock and 6 h of recovery. (C) Similar
experiment using 50 WM cadmium chloride and 6 h of recovery.
The levels of L-tubulin were measured in all cases, as a control
of sample loading. Ten Wg of total protein extract was loaded
in each lane. All other conditions were as in Fig. 1. The experi-
ments were repeated at least twice with similar results.
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3.2. Protein synthesis
A possible explanation for the lack of HSP70 ex-
pression in cells treated with BSO plus 200 WM cad-
mium is that the execution of necrosis may cause a
general inhibition of protein synthesis or an acceler-
ation of protein degradation. For this reason, we
measured the rate of valine incorporation, as an in-
dication of total protein synthesis activity, as well as
the protein content per cell, in cultures treated with
200 WM cadmium, with or without pre-incubation
with BSO. It was observed that BSO plus cadmium
decreased valine incorporation, but the decrease was
not greater than that caused by cadmium alone (Fig.
3A). However, BSO potentiated the cadmium-pro-
voked decrease in protein content (Fig. 3B). The de-
crease in protein content in BSO plus cadmium-
treated cells was specially evident at 3 and 6 h of
recovery, which roughly coincides with the timing
of expression of necrotic markers [16]. Interestingly,
the administration of the antioxidant agent NAC at
the end of treatment with BSO plus cadmium (i.e., at
0 h of recovery) greatly prevented the decrease in
protein content (Fig. 3B), and at the same time in-
hibited the execution of necrosis and restored the
execution of apoptosis (Fig. 3C). The capacity of
such a post-treatment with NAC and other antioxi-
dants to modulate cell death has been analyzed with
more detail elsewhere [17].
These observations prompted us to re-examine the
modulation of HSP70 protein levels in cells treated
with 200 WM cadmium, either with or without pre-
incubation with BSO and with or without post-treat-
ment with NAC. For comparison we also measured
the levels of other speci¢c proteins, namely the stress-
related protein HSP60 and the death regulatory pro-
teins Bcl-2 and Bax. The results are indicated in Fig.
3D. Treatment with BSO plus cadmium suppressed
Bax expression, but apparently increased Bcl-2 ex-
pression, and potentiated the increase in HSP60 ex-
pression, when compared to treatment with cadmium
alone. Nevertheless, these relative increments in Bcl-2
6
Fig. 3. Modulation of protein synthesis, protein content, cell
death and speci¢c protein expression by cadmium, BSO and
NAC. (A) cells were incubated with [3H]valine alone (Cont)
and in the presence of 200 WM cadmium chloride, either with
(BSO/Cd) or without (Cd) pre-incubation with BSO. The acid-
insoluble radioactivity was determined at the indicated times.
(B^D) Cells were left untreated (Cont) or treated with 200 WM
cadmium chloride, either with (BSO/Cd) or without (Cd) pre-in-
cubation with BSO. In some determinations, 15 mM NAC was
added at the beginning of recovery after BSO plus cadmium
treatment (BSO/Cd/NAC). (B) Changes in protein content at
the indicated times of recovery. The results (mean þ S.D. of
three determinations) are expressed in relation to that obtained
with control cells, which was given the arbitrary value of 100.
The approximate protein content in controls was 140 Wg/106
cells. (C) Frequency of apoptotic and necrotic cells, at 6 h of
recovery. (D) Relative levels of HSP70, HSP60, Bcl-2 and Bax,
at the indicated times of recovery. The experiments in A, C and
D were repeated at least twice with similar results. All other
conditions were as in Figs. 1 and 2.
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and HSP60 levels in BSO plus cadmium-treated cells
were considerably reduced when corrected for the
above-recorded changes in total protein content (re-
sults not shown). Whatever the case, the inhibition of
Bax and the relative increase in Bcl-2 and HSP60
seemed to be late events associated to the execution
of necrosis, since they were prevented by post-treat-
ment with NAC. By contrast, the abrogation of
HSP70 induction by BSO plus 200 WM cadmium
appeared as an early regulated event, prior to the
execution of necrosis, since it was not prevented by
post-treatment with NAC.
3.3. HSP70 mRNA expression
The results in Fig. 3D led us to analyze the mod-
ulation of HSP70 at the RNA level, since HSP70
mRNA expression was rapidly stimulated upon cad-
mium administration [14]. As a control, we also mea-
sured the levels of c-jun and c-fos mRNAs, since
these transcripts were also rapidly induced by cadmi-
um in U-937 cells [15,20]. The results are indicated in
Fig. 4. It was observed that the amount of HSP70
mRNA level had already increased at 2 h of treat-
ment with 200 WM cadmium alone, but the increase
was almost suppressed by pre-incubation with BSO.
Although BSO also reduced the cadmium-provoked
increase in c-jun mRNA level, it did not inhibit the
increase in c-fos mRNA, therefore excluding the pos-
sibility of a generalized RNA degradation or collapse
of the transcriptional machinery.
3.4. HSF1 expression and activity
The lack of HSP70 mRNA induction in cells
treated with BSO plus 200 WM cadmium pointed to
a blockade of the HSF1-directed transcription. We
recently reported that BSO did not prevent the acti-
vation of the p38 and ERK1/2 mitogen-activated
protein kinases, which seemed to be speci¢cally re-
quired for the cadmium-provoked HSF1 hyperphos-
phorylation ([16] and references therein). Hence, we
centered the attention on HSF1 expression, oligo-
merization and binding. The results are represented
in Fig. 5. It was observed that HSF1 was constitu-
tively present in non-stressed cells, as revealed by
immunoblot assays, and its level was not signi¢cantly
altered during treatment with the stress inducers,
under conditions which caused either apoptosis
(200 WM cadmium alone, and heat shock with or
without BSO) or necrosis (BSO plus 200 WM cad-
mium) (Fig. 5A). By contrast, while the apoptosis-
inducing treatments caused HSF1 trimerization and
binding to the HSE consensus sequence, the necrosis-
inducing treatment did not, as revealed by immuno-
blot assays and gel mobility shift assays, respectively
(Fig. 5B,C). Hence, the inability of BSO plus 200 WM
cadmium to induce the stress response may be attrib-
uted to a failure in the early steps of HSF activa-
tion.
Fig. 4. Induction of speci¢c gene transcripts by cadmium, and
its modulation by BSO. Total RNA samples (10 Wg per lane)
extracted from untreated cells (Cont), from cells incubated with
BSO alone (BSO), and from cells treated for 2 h with 200 WM
cadmium chloride, either with (+) or without (3) pre-incuba-
tion with BSO, were assayed by Northern blot using HSP70-,
c-fos- and c-jun-speci¢c cDNA probes. The amount of rRNAs
in the membrane was visualized by ethidium bromide staining,
as a control of sample loading and transfer. All other condi-
tions were as in Fig. 1.
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4. Discussion
The results in this work corroborate and extend
our earlier observations indicating that cadmium in-
duces apoptosis in U-937 promonocytic cells, and
that BSO increases the cadmium toxicity [15^17].
BSO potentiated apoptosis and also caused necrosis
to some extent when combined with 50 and 100 WM
cadmium, and switched the mode of death from apo-
ptosis to necrosis when combined with 200 WM cad-
mium. A possible explanation is that the BSO-pro-
voked depletion of GSH reduces the amount of
thiol^cadmium interactions, hence increasing the in-
tracellular concentration of free, active Cd2 ions.
This may explain the reason by which BSO did not
signi¢cantly alter the toxicity of heat shock.
In addition, the present results demonstrate that
BSO abrogate the induction of HSP70 expression
by 200 WM cadmium, indicating that the activation
of the stress response is compatible with apoptosis
but not with necrosis in this experimental system.
Our observations show some coincidences, but also
some discrepancies with the results of other authors.
For instance, Rokutan et al. [21] also reported that
pre-incubation with BSO inhibited the stimulation of
HSPs expression and HSF1 binding by di¡erent
stress inducers in primary cultures of pig gastric mu-
cosal cells. However, they attributed the inhibition of
the stress response only to the GSH depletion, since
the treatments did not cause necrosis. By contrast, in
our experiments the abrogation of the stress response
by BSO plus 200 WM cadmium was a consequence of
necrosis and not of GSH depletion itself, since BSO
did not cause necrosis nor prevent HSP70 induction
when used in combination with heat shock or 50 WM
cadmium. On the other hand, some authors have
indicated that BSO and other GSH-depleting agents
potentiated HSP70 induction by cadmium and other
stress inducers in HepG2 hepatoma cells [22], in hu-
man amniotic WISH cells [23] and in C6 rat glioma
cells [24]. Our results partially agree with these re-
ports, since we also observed that BSO potentiated
the induction of HSP70 expression by 50 WM cadmi-
um, a treatment which preferentially caused apopto-
sis. However, since the authors did not analyze cell
death, further confrontation between our results and
theirs may not be carried out. Finally, it must be
noted that HSP70 induction was compatible with
Fig. 5. HSF1 expression and processing during treatment with
cadmium and heat, and their modulation by BSO. U-937 cells
were either left untreated (Cont), incubated with BSO alone
(BSO), or treated for 1 or 2 h with 200 WM cadmium chloride
or heat, either with (+) or without (3) pre-incubation with
BSO. (A) Relative levels of HSF1 and L-tubulin (included as a
control) proteins, as determined by immunoblot using SDS^
PAGE. (B) HSF1 trimerization, as determined by immunoblot
using native PAGE. T and M indicate the location of HSF1
trimers and monomers, respectively, according to the descrip-
tion of Zou et al. [36]. (C) HSF1 binding activity, as demon-
strated by gel retardation assays. As controls for binding specif-
icity, aliquots from cadmium-treated cells (Cd) were incubated
with an anti-HSF1 antibody (HSF1ab) or with 50-fold excess
related (HSE) or unrelated (AP-1-recognizing) oligonucleotides.
HSF1 indicates the protein^DNA complex, while the arrow in-
dicates free oligonucleotide. All other conditions were as in
Figs. 1 and 2.
BBAMCR 14716 22-1-01
A. Gala¤n et al. / Biochimica et Biophysica Acta 1538 (2001) 38^4644
the generation of both apoptosis and necrosis by
tobacco smoke in U-937 cells [6]. Taken together,
these observations indicate that the regulation of
the stress response and its relationship with cell death
depends very much on both the cell type and the
stress inducer used.
The inhibition of the stress response by BSO plus
200 WM cadmium may not be attributed to a gener-
alized cellular collapse. In fact, necrosis was still
compatible with essential functions such as transcrip-
tion (manifested by c-fos mRNA induction), trans-
lation (manifested by Bcl-2 and HSP60 protein ex-
pression), and mitogen-activated protein kinase
stimulation [16]. Instead, it seems to be speci¢cally
due to the inhibition of HSF1 activation, as mea-
sured by the absence of trimerization and binding.
We have recently reported that BSO potentiates the
cadmium-induced intracellular oxidation, as mea-
sured by H2O2 accumulation [17]. This might explain
at least part of our results, since excessive H2O2 pro-
duction was reported to inhibit HSF1 binding activ-
ity by inactivating the cysteine residues present in the
DNA binding domain ([25] and references therein).
We ignore whether such an increased oxidation may
also explain the failure of HSF1 oligomerization. In
fact, the initial steps of HSF1 activation, namely,
release from putative repressor molecule(s) and oli-
gomerization, are very complex and still little known
(as an example see [26]).
Although the expression of proteins other than
HSP70 was only measured for control purposes,
the obtained results deserve some comment. Firstly,
it might be surprising that BSO, which abrogated
HSF1 activation by 200 WM cadmium, did not inhib-
it HSP60 expression. Nevertheless, earlier reports in-
dicated that the expression of this HSP is weakly
dependent on HSF1, since cadmium and other stres-
sors which greatly activated HSF1 caused a little or
null increase in HSP60 expression in di¡erent cell
systems ([27,28], among others). In addition, it could
be surprising that necrosis occurs concomitantly with
an increase in Bcl-2 levels, since Bcl-2 may protect
the cells from both apoptosis and necrosis [29,30].
However, the selection between apoptosis and ne-
crosis depends on the concurrence of multiple fac-
tors, the study of which is beyond the scope of this
work. For instance, Bcl-2 activity depends on its
phosphorylation state and intracellular localization
[31,32], which could be modi¢ed during the execution
necrosis. In addition, since Bax seems to mediate the
release of cytochrome c from mitochondria (for re-
view see [33]), the suppression of Bax expression dur-
ing necrosis (Fig. 3D) could prevent the cytochrome
c-mediated activation of caspase-3, forcing the cells
to die by necrosis [34,35]. This problem, which was
already approached in another work [17], is under
investigation in our laboratory.
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